Sequencing Sheds Light on the Natural History of Hepatitis C Infection
in Patients Who Fail Treatment – Tamer Abdelrahman, et al.
Source: Hepatology January 2015; Volume 61, Issue 1, pages 88–97
reinfection among injecting drug users with history of HCV, along with
reports of sexually transmitted HCV infection and reinfection in
HIV-infected men who have sex with men. This research investigated viral
quasispecies dynamics in patients who failed HCV treatment to
determine whether treatment failure was associated with reinfection or
reemergence of preexisting infection. Previous studies interpreted the
evidence as reinfection; this study identified the subjects as having
preexisting resistant HCV variants.
HCV strains are more likely the reason for failure to achieve a
sustained virological response (SVR) in these study subjects. This
could be the result of superinfection or a limitation on the ability to
test these HCV strains.
Few words cause as much fear in me as “superinfection.” What this study
did not discuss is whether the lack of SVR could be connected to
immune factors in this study group.
Source: Journal of Viral Hepatitis December 2014; Volume 21, Issue 12, pages 938–943
cross-sectional study was to see if chronic hepatitis C virus (HCV)
infection was associated with low muscle mass among adults.
U.S., people with chronic HCV had a higher prevalence of low muscle
mass compared to uninfected persons (13.8% vs. 6.7%). Even HCV+ persons
without significant liver fibrosis had lower muscle mass.
Low muscle mass is a risk factor for osteoporosis. This study
strengthens the argument that we should treat people with chronic HCV,
regardless of fibrosis stage.
Source: Journal of Clinical Gastroenterology published ahead-of-print October 8, 2014
conditions that can cause cirrhosis, a severe scarring of the liver.
This study assessed the prevalence of cirrhosis in the US, and defined
some of the characteristics of this potentially deadly condition.
higher in the U.S. than previously estimated (633,323 now versus
previously estimated 400,000 adults). The researchers believe that the
prevalence is even higher since this research relied on data from the
NHANES survey, which did not collect data from people who were in the
military, prison, hospitalized, homeless, or institutionalized.
hepatitis C were contributing factors for the majority of those with
cirrhosis. Non-Hispanic blacks and Mexican Americans, those living
below the poverty level, and those with less than a 12th grade
education had the highest prevalence of cirrhosis. Nearly 70% of those who have cirrhosis may not know they have it.
The most common factors associated with cirrhosis are preventable –
hepatitis C, diabetes, and alcohol abuse. Hepatitis C is curable; a
public health program that identifies and cures this virus may reduce
the burden of cirrhosis.
Source: Journal of Viral Hepatitis published ahead-of-print December 15, 2014
children, and little is known about the cognitive effects of hepatitis
C in young patients. This Egyptian study compared cognitive function
in 35 HCV-positive children to 35 HCV-negative children. Compared to
HCV-negative children, the children with HCV had reduced function in
the areas of vocabulary, comprehension, memory, abstract visual
reasoning test, quantitative reasoning test, and intelligence
Children with chronic HCV in its early stages showed signs of
cognitive impairment, particularly with memory. There appeared to be a
correlation between cognitive function and immune response as measured
by the production of cytokines.
This study is particularly heart breaking. Children are often the last
to be studied, and the last to be treated. We tend to be afraid to
treat children, understandably concerned that we may injure them. This
study represents the tip of the iceberg, telling us how little we know
about HCV in children.
Source: Journal of Viral Hepatitis January 2015; Volume 22, Issue 1, pages 18–24
assessed the relationship between chronic hepatitis C virus (HCV)
infection and survival rates. There were 675 subjects (nearly 80%
male), enrolled in two detoxification units, with a median follow-up of
mortality rate was high for those with alcohol-related liver disease,
regardless of HCV-status; more than 11% died (78 subjects). Risk of
death was increased among younger HCV-positive participants compared to
those who were HCV-negative. HCV/HIV co-infection was associated with
increased risk of death.
Editorial Comment: This study speaks for itself. I can only add that if alcohol is a problem for you, please get help.